Q9FYZ9 AF NFT

Benzoate carboxyl methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibspml32n6nvhnqorngawowzsvic6wqh3kg3p24hp2utbae4vrt4q/metadata.json
IPFS of structure file: 
bafybeih2wbp3mpvkejrw5rfi5hiplrcu4prh26uxtofeohrhepkjrsbxpe/AF-Q9FYZ9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7D876F364ae377f396cf395997491B94DB9a3335
First NFT owner address (bech32): 
genesis10krk7dj2udml89k089vewjgmjnde5ve4c59xv9
Current NFT ID #40839 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
40839
Accession (UniProt):
Q9FYZ9
Name::
Benzoate carboxyl methyltransferase
Experimental Method:
Predicted structure
Sequence source:
ANTIRRHINUM MAJUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9FYZ9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9FYZ9|BAMT_ANTMA Benzoate carboxyl methyltransferase OS=Antirrhinum majus OX=4151 GN=BAMT PE=1 SV=1 MKVMKKLLCMNIAGDGETSYANNSGLQKVMMSKSLHVLDETLKDIIGDHVGFPKCFKMMDMGCSSGPNALLVMSGIINTIEDLYTEKNINELPEFEVFLNDLPDNDFNNLFKLLSHENGNCFVYGLPGSFYGRLLPKKSLHFAYSSYSIHWLSQVPEGLEDNNRQNIYMATESPPEVYKAYAKQYERDFSTFLKLRGEEIVPGGRMVLTFNGRSVEDPSSKDDLAIFTLLAKTLVDMVAEGLVKMDDLYSFNIPIYSPCTREVEAAILSEGSFTLDRLEVFRVCWDASDYTDDDDQQDPSIFGKQRSGKFVADCVRAITEPMLASHFGSTIMDLLFGKYAKKIVEHLSVENSSYFSIVVSLSRR